Off-Label Prescriptions in Dermatology: Challenges of New Routes of Administration for Certain Old Drugs

被引:1
|
作者
Tasic-Kostov, Marija [1 ]
Ilic, Dusan [1 ]
机构
[1] Univ Nis, Fac Med, Dept Pharm, Nish, Serbia
关键词
off-label drug; dermatology; compounded drugs; drug vehicle; INFANTILE HEMANGIOMAS; TOPICAL PROPRANOLOL; SPIRONOLACTONE; THERAPY; SAFETY; ACNE; GEL;
D O I
10.5937/afmnai37-25282
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
"Off-label drug use" refers to the prescription of medications, with reference to indications, dosage, dosage form, patient group or route of administration, which are officially unapproved. Recently, new indications for some drugs have emerged and few of them are being used off-label to treat topically a variety of dermatological conditions. Off-label use is more common in dermatology than in other medical specialties, and those drugs are basically available as compounded formulations, but the choice of a proper vehicle and safety of extemporaneous drug preparation intended for topical use are usually neglected in case of systemic drugs. Moreover, the bases commonly used as vehicles for extemporaneous dermatological preparations are stabilized with traditional surfactants known for their potential to irritate skin, while inflammatory dermatoses can worsen when exposed to irritants In this paper, we have listed several systemic drugs which are being used in topical treatment of some frequent dermatological conditions, but not according to their officially approved indications. The choice of drugs was made according to the topical off-label dermatological prescriptions obtained from public pharmacies. The aim was also to review data related to, in our opinion, two major drawbacks of using off-label topical drugs: safety data on the use of the final dermal preparation and scientific information relevant for the choice of a proper topical vehicle for specific drug and proper stability evaluation.
引用
收藏
页码:131 / 138
页数:8
相关论文
共 43 条
  • [41] Use of unapproved or off-label drugs in Japan for the treatment of graft-versus-host disease and post-transplant viral infection
    Kuwatsuka, Yachiyo
    Atsuta, Yoshiko
    Hirakawa, Akihiro
    Uchida, Naoyuki
    Inamoto, Yoshihiro
    Najima, Yuho
    Ikegame, Kazuhiro
    Eto, Tetsuya
    Ozawa, Yukiyasu
    Ichinohe, Tatsuo
    Inoue, Masami
    Kimura, Takafumi
    Okamoto, Shinichiro
    Miyamura, Koichi
    Fukuda, Takahiro
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 112 (06) : 841 - 850
  • [42] Real-world Performance of a New Strategy for Off-Label Use of Guselkumab in Moderate to Severe Psoriasis: Super-Responder Patients as the Epitome of Efficacy and Optimisation
    Herranz-Pinto, Pedro
    Alonso-Pacheco, Maria Luisa
    Feltes-Ochoa, Rosa
    Mayor-Ibarguren, Ander
    Servera-Negre, Guillermo
    Busto-Leis, Jose Manuel
    Gonzalez-Fernandez, Maria Angeles
    Herrero-Ambrosio, Alicia
    CLINICAL DRUG INVESTIGATION, 2023, 43 (07) : 517 - 527
  • [43] Current Evidence in the Systemic Treatment of Brain Metastases from Breast Cancer and Future Perspectives on New Drugs, Combinations and Administration Routes: A Narrative Review
    Garrone, Ornella
    Ruatta, Fiorella
    Rea, Carmen Giusy
    Denaro, Nerina
    Ghidini, Michele
    Cauchi, Carolina
    Bareggi, Claudia
    Galassi, Barbara
    Merlano, Marco C.
    Rosenfeld, Roberto
    CANCERS, 2024, 16 (24)